Hospital das Clínicas of Ribeirão Preto Medical School
Ribeirão Preto, São Paulo, 14048-900, Brazil
NCT Number: NCT07445178
The objective of this retrospective cohort observational study is to identify variables related to the recurrence of colorectal lesions after snare polypectomy resection in colonoscopies. It also aims to evaluate the safety of the procedure. The main questions to be answered are:
* What endoscopic characteristics are most related to recurrence? * What adverse events are related to the procedure?
The researchers will perform a chart analysis looking for demographic, clinical, endoscopic, and histological variables in order to identify which factors are most closely linked to the recurrence of previously resected lesions.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ribeirão Preto, São Paulo, 14048-900, Brazil
However, despite the high initial success rate, local recurrence at the resection site remains a relevant clinical outcome, especially in larger lesions, piecemeal resections, and cases with advanced histological characteristics. The literature shows heterogeneity regarding independent predictors of recurrence, particularly when analyzed using time-to-event methodology.
Given this scenario, it becomes essential to identify clinical, endoscopic, and histopathological variables associated with local recurrence, allowing for better risk stratification and optimization of surveillance protocols.
Primary Objective:
To identify variables associated with local recurrence after loop colorectal polypectomy.
Secondary Objectives:
To evaluate the occurrence of metachronous adenomas; To assess the safety of the procedure through the analysis of related adverse events; To determine independent predictors of recurrence using time-to-event analysis;
Inclusion criteria
Patients ≥18 years; Underwent snare colorectal polypectomy (with or without thermal energy); Availability of histopathological examination; At least one documented follow-up colonoscopy;
Exclusion criteria
Resection by non-loop-based techniques (e.g., isolated ESD); Absence of endoscopic follow-up; Incomplete clinical or histological data;
The lesions were described according to:
Size: dichotomized into
Resection technique:
Histopathology:
6.2 Secondary Outcomes Metachronous adenoma: development of a new lesion at a site distinct from the initial resection.
Adverse events related to the procedure, including:
The following variables were collected:
7.1 Clinical
7.2 Endoscopic
7.3 Histological
This study will allow:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Between the years 2023 and 2025.
Presence of a visible lesion at the scar site of a previous polypectomy, histologically confirmed as adenomatous, serrated, or neoplastic tissue, obtained by biopsy or new resection.
Time frame: Between the years 2023 and 2025.
Development of a new adenomatous or serrated lesion at a site different from the area of previous resection, identified during follow-up colonoscopy and confirmed histologically.
Time frame: Between the years 2023 and 2025.
Complications attributable to snare polypectomy, classified as: immediate bleeding; delayed bleeding; perforation; post-polypectomy syndrome (when applicable); and need for hospitalization or surgical intervention.
University of Sao Paulo
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718919
Colo-rectal Cancer, Colonic Diseases
Cagliari, Italy
View Trial DetailsNCT05708950
Adnexal Diseases, Breast Cancer
Santa Monica, California, United States
View Trial DetailsNCT04223141
Colo-rectal Cancer, Colonic Diseases
Vejle, Denmark
View Trial DetailsNCT07517848
Colo-rectal Cancer, Colonic Diseases
Manisa, Turkey (Türkiye)
View Trial Details